Imagene develops an AI platform for biomarkers identification and response prediction that delivers real-time molecular analysis using only a digitized biopsy image. We drive a new approach for treatment response prediction that encapsulates the uniqueness of each patient, bringing cancer care closer to reaching the full potential of precision medicine.